NMPA Approval

Glycopyrronium Bromide Powder for Inhalation, Hard Capsules

Approval Number

H20180002

Registration Date

January 30, 2019

Previous Approval Numbers

H20180002

Drug Information

Generic Name

格隆溴铵吸入粉雾剂用胶囊

Trade Name

希润

Dosage Form

胶囊剂

Strength

50μg(以C19H28NO3计)

Drug Type

化学药品

Registration Date

January 30, 2019

Expiry Date

February 1, 2023

Company Address

6343 Risch,Switzerland

Company Address

Schaffhauserstrasse，4332 Stein, Switzerland

Empowering clinical research with data-driven insights and AI-powered tools.

格隆溴铵吸入粉雾剂用胶囊 - NMPA 批准文号 | MedPath